Medical/Pharmaceuticals
JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma
SHANGHAI, March 8, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of Carteyva® (relmacabtagene autoleucel inje...
2023-03-08 17:30
4977
IVI launches global study to determine the burden of HPV among girls and women
SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced the start of a multi-country study to better understand...
2023-03-08 16:40
2662
ONEDAY BIOTECH to unveil 'One Drilling System' at IDS 2023
* One Drilling System Completing the Implant Procedure with Just One Drilling Exclusively * Company Specializing in Implants Pursuing 'One-Day-Completion Implant' SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- ONEDAY BIOTECH (CEO Kim Jin -hwan), a dental product manufacturer specializing in...
2023-03-08 07:00
4946
Martech platform Ortto celebrates record growth on the anniversary of its rebrand
The unified customer data, analytics, and marketing automation platform Ortto, formerly Autopilot, continues to see double-digit monthly growth a year on from its rebrand. The martech company now has more than 3,000 customers globally and was recognized in 49 categories in G2's biannual report. ...
2023-03-08 03:14
3679
Argon Medical Devices Modernizes Portal Vein Access with the Launch of the TRAVELER™ Series
PLANO, Texas, March 8, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access pr...
2023-03-08 01:39
3838
Medlab Asia and Asia Health returns to Thailand after securing deals worth US$35m in 2022
BANGKOK, March 7, 2023 /PRNewswire/ -- Informa Markets and IMPACT Exhibition Management Co.,Ltd. have confirmed that Medlab Asia and Asia Health, a major healthcare event, will return toThailand following the success of the 2022 edition, after shining a spotlight on the growth of healthcare and l...
2023-03-07 16:49
3392
Japan's Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients
CAMBRIDGE, Mass., March 7, 2023 /PRNewswire/ -- Saitama Medical University International Medical Center, one ofJapan's leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize global real-world data to better understand rare diseases...
2023-03-07 13:00
3002
Ceva Santé Animale calls to speed up development of critical new vaccines at VIV Asia 2023
LIBOURNE, France, March 7, 2023 /PRNewswire/ -- Ceva Santé Animale, (Ceva), the #5 animal health company present in 110 countries, participates in the VIV Asia inBangkok, Thailand. Earlier today, the One Health company held the "Ceva Innovation Day" pre-opening symposium, featuring a keynote spee...
2023-03-07 12:00
5364
GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS
NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS(Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations o...
2023-03-07 10:00
3596
Hummingbird Bioscience Exercises Its Option to License the Clinical Trial Results from Cancer Research UK to Support Further Development of HMBD-001
SINGAPORE and LONDON, March 6, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, and Cancer Research Horizons, the innovation arm of Cancer Research UK (CRUK), today...
2023-03-06 21:00
2805
Confirmatory clinical trial of Liwen RF™ ablation system in China concluded
HANGZHOU, China, March 6, 2023 /PRNewswire/ -- On March 3, Venus Medtech ( Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ablation system developed by the Company has successfully enrolled one patient at West China Hospita...
2023-03-06 07:29
3794
Results of CLDN18.2-targeting Immuno-PET Probe for Non-invasive Imaging in Gastrointestinal Tumors Published
SUZHOU, China, March 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announces that the study ...
2023-03-03 14:56
3982
AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL®, the Progressive Extended Depth-of-Focus IOL
SHANGHAI, March 3, 2023 /PRNewswire/ -- AffaMed Technologies ("AffaMed"), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of the first patient implantation in the Registrational Clinical Trial of its MINI WELL® progressive Extended Depth-o...
2023-03-03 09:00
4686
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
LONDON and HONG KONG, March 2, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the 'SAB') to provide strategic input based on their scientific knowledge and c...
2023-03-02 20:00
4088
AIRS Medical Applauded by Frost & Sullivan for Reducing MRI Equipment's Exam Wait Times with Its SwiftMR™ Technology
SwiftMR™ improves image quality of MRI scans, enables easy installation and use, andadapts to healthcare providers' existing scanners because it is a stand-alone offering. SAN ANTONIO, March 2, 2023 /PRNewswire/ -- Recently, Frost & Sullivan researched the artificial intelligence (AI)-powered ma...
2023-03-02 20:00
3045
Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376
SHANG HAI, March 2, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that it has entered into an exclusive Out-License Agreement (the "Agreement" hereafter) with Shanghai Allist Pharmaceuticals Co., Ltd., ("Allist" hereafter) for the further ...
2023-03-02 19:15
5474
DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Debiopharm obtains global rights from Novo Nordisk for the development of their
ubiquitin-specific protease 1 (USP1) inhibitor
LAUSANNE, Switzerland, March 2, 2023 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2023-03-02 09:00
3885
ClinChoice Acquires CROMSOURCE, Expanding its Global Presence
PHILADELPHIA, SHANGHAI and VERONA, Italy, March 2, 2023 /PRNewswire/ -- ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters inVerona, Italy and its US headquarters ...
2023-03-02 04:12
4876
AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario
TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company inHamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated for high volum...
2023-03-01 22:00
2370
National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations
Annual conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices achieving quality cancer care delivery, inOrlando March 31—April 2, 2023. PLYMOUTH MEETING, Pa., March 1, 2023 /PRNewswire/ -- ...
2023-03-01 21:33
2273
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Nuix Neo Generative AI Framework
[Picked up by 262 media titles]
2026-10-08 08:02Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
13398
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
11172
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
10789
